A good obesity evaluation measures adiposity (BMI and waist), screens for the conditions obesity causes or worsens (blood pressure, A1c/glucose, lipids, liver, sleep apnea), reviews medications and eating behaviour, and checks the thyroid once. Broad hormone panels are not routine — they are added only when specific signs point to a secondary or endocrine cause.
Two messages, held at once
This page is built around two ideas that sound contradictory but are both true. Good evaluation lives in the tension between them.
The skill is not "test everything" or "test nothing." It is testing what matters — measuring adiposity properly, screening for the harm obesity does, and reserving deeper endocrine or secondary testing for people whose story or exam points to it. This is the "TEST what matters" step of our method. → The W8Experts Clinical Approach
Step 1 — Measure adiposity properly (not just BMI)
BMI is a useful population screen and the entry point for most guidelines, but it is a crude individual measure: it doesn't distinguish fat from muscle, doesn't show where fat sits, and misclassifies muscular people and some older or Asian populations. Use it — but don't stop there. → BMI, Body Fat & Body Composition
- Waist circumference (or waist-to-height ratio). Central/visceral fat drives most metabolic risk, so waist adds information BMI misses — especially at "normal" or "overweight" BMI. A simple, cheap, high-value measurement. Grade A 🟢
- Body composition (DXA/BIA). Useful for tracking fat vs lean mass over time, particularly during rapid loss, but not required for everyone. BIA is convenient and noisy; DXA is more accurate. Don't over-interpret a single "lean mass" figure. Grade B 🟡 → Weight-Loss Lab Library
- Ethnicity-specific thresholds. Metabolic risk appears at lower BMI/waist in South Asian and some other populations; apply lower cut-points where appropriate. Grade B 🟡
The point of Step 1 is that the goal is never a number on the scale — it's understanding how much excess adiposity there is and where it sits.
Step 2 — Screen for what obesity actually does
This is the part almost everyone with obesity should have, because it looks for treatable harm regardless of cause. These findings frequently change management even when the weight itself is "ordinary."
- Blood pressure. Obesity-associated hypertension is common and consequential; measure it. Grade A 🟢
- Glycaemia — A1c and/or fasting glucose. Screens for prediabetes and type 2 diabetes, which reframes goals (diabetes remission/prevention) and treatment choice. Grade A 🟢 → Obesity & Diabetes
- Lipid panel (with triglycerides). Dyslipidaemia clusters with visceral adiposity and drives cardiovascular risk. Grade A 🟢 → Obesity & Cardiovascular Health
- Liver — ALT/AST and MASLD risk. Metabolic (dysfunction-associated) fatty liver is common in obesity. Normal liver enzymes do not exclude it, and the question that matters is fibrosis, not just fat. Use a FIB-4 (from age, AST, ALT, platelets) to risk-stratify, and reserve elastography for indeterminate/higher risk. Don't just find fat — find risk. Grade A 🟢 → Do I Have Fatty Liver? · FIB-4 Explained
- Obstructive sleep apnea. Under-diagnosed and high-yield: it worsens metabolic health, blood pressure and quality of life, and it's treatable. Screen symptomatically (snoring, witnessed apneas, daytime sleepiness) and test when suspected. Tirzepatide is now FDA-approved for moderate-to-severe OSA in adults with obesity, so the finding can also shape treatment. Grade A 🟢
Step 3 — Review medications and behaviour
Two of the highest-yield, lowest-cost parts of the whole evaluation — and the two most often skipped.
- Medication review. Several drug classes genuinely cause or worsen weight gain: some antipsychotics, certain antidepressants, some antiseizure drugs, corticosteroids, some diabetes drugs (insulin, sulfonylureas), and others. This isn't an excuse — it's a fixable clue. Sometimes a weight-neutral or weight-favourable alternative exists. Grade A 🟢 → When Weight Change Is a Red Flag
- Eating behaviour and disordered eating. Screen for binge-eating disorder (the most common eating disorder, and common in people seeking weight treatment), night-eating, and a history of restriction/purging. This changes the plan: some treatments help binge eating, and starting certain interventions without recognizing an eating disorder can do harm. Grade A 🟢 → Mental Health & Obesity
- Physical activity and function. Not to "prescribe more exercise" as a weight cure (it's a weak weight-loss lever), but to gauge baseline activity, strength and mobility — which matter for muscle preservation and maintenance. Grade B 🟡 → Exercise, Muscle & Body Composition
- Sleep, stress, life context. Poor sleep raises appetite; shift work, stress, food access and socioeconomic factors all shape weight. These are modifiable contributors worth naming. Grade B 🟡
Step 4 — Check the thyroid once (and interpret it soberly)
Thyroid disease is common and easy to check, so a one-time TSH is reasonable in most weight evaluations. But set expectations: untreated hypothyroidism causes only modest weight gain (much of it fluid), a normal TSH effectively rules it out as a major driver, and treating a normal thyroid does not cause weight loss. Chasing "borderline" or "subclinical" numbers to explain significant obesity is usually a dead end. For the full thyroid picture, see our sister site. → Obesity & Hormones · Thyroid & weight (Hashiexperts)
Grade A 🟢 (check once; the answer is usually "your thyroid is fine").
Step 5 — Targeted endocrine and secondary evaluation (only when the story points there)
Here is where "test what matters" earns its keep. Add these when specific pointers are present, not by reflex.
- PCOS (women). Consider with irregular cycles, androgen excess (acne, hirsutism) or fertility concerns. PCOS genuinely tangles hormones and weight and changes management. Grade A 🟢 → PCOS & Weight
- Menopause / perimenopause. Falling estrogen shifts fat toward the abdomen and changes body composition; relevant context for women in midlife, though not a "test." → Menopause & Weight (MenoExperts) Grade A 🟢
- Testosterone (men). Check when symptoms of hypogonadism are present — but remember the link is bidirectional: excess visceral fat lowers testosterone, and weight loss often raises it. Testosterone is not a weight-loss treatment. → Men's Health (TestoExperts — forthcoming) Grade B 🟡
- Cushing's syndrome. Test when the picture fits: rapid central weight gain, purple striae, easy bruising, thin skin, proximal muscle weakness, uncontrolled hypertension/diabetes. Rare, but important and treatable — routine cortisol testing for common obesity is not useful. Grade A 🟢 → When Weight Change Is a Red Flag
- Hypothalamic / pituitary causes. Consider with rapid or severe weight gain plus features such as headaches, visual changes, menstrual disturbance, milk discharge (prolactin), or a history of brain injury, surgery or radiation. Hypothalamic obesity (e.g., after craniopharyngioma treatment) and pituitary disease are uncommon but genuinely secondary. Grade B 🟡
- Genetic / syndromic obesity. Consider with early-onset (childhood) severe obesity, extreme hyperphagia, developmental features or a strong family pattern — monogenic (e.g., MC4R, leptin/LEPR, POMC) and syndromic forms (Prader-Willi, Bardet-Biedl) exist, and some (POMC, LEPR, Bardet-Biedl) have a targeted treatment (setmelanotide). Grade B 🟡 → Genetics of Obesity
- Other secondary contributors. Certain medications (above), and less commonly other endocrine disease, belong here too. → When Weight Change Is a Red Flag
What is NOT useful: reflex broad "hormone panels," fasting-insulin/HOMA-IR fishing expeditions, "adrenal fatigue" testing, and commercial "hormone imbalance" or "functional-medicine metabolic" panels marketed as the key to weight loss. They generate false positives, cost money and rarely change management. Grade A 🟢 → Weight-Loss Lab Library
What the evidence says
- What we know: Measuring adiposity beyond BMI (waist), and screening for the harms obesity causes (blood pressure, glycaemia, lipids, liver/MASLD, sleep apnea), reliably changes management. A one-time thyroid check is reasonable. Medication and eating-behaviour review are high-yield and cheap.
- What we think: Deeper endocrine or secondary testing should be targeted to clinical pointers, not applied reflexively — and yet a real secondary cause should not be missed by assuming "it's just lifestyle."
- What we don't know: The optimal, universally agreed panel; body-composition testing thresholds that change outcomes for everyone; the best way to operationalize risk-based selection in practice.
- What patients should do: Expect adiposity measurement plus a metabolic/liver/sleep screen and a medication and behaviour review — not a giant hormone panel. Ask which result would change the plan; if a test wouldn't, question doing it. → The W8Experts Clinical Approach
MYTHS & MISCONCEPTIONS: evaluating obesity (20+)
“Everyone with obesity needs a full hormone workup.”
Short answer: No — reflex hormone panels rarely change management.
Evidence: Most obesity is polygenic and multifactorial; broad testing mostly returns normal.
Bottom line: Test with a reason, not by reflex.
Evidence: 🟢 A · Established
“There's no point evaluating — it's just lifestyle.”
Short answer: No — a minority have a treatable secondary or contributing cause, and everyone benefits from screening for obesity's harms.
Evidence: Medications, hypothyroidism, Cushing's, PCOS, sleep apnea and others do change management when present.
Bottom line: Don't assume lifestyle; screen properly. → When Weight Change Is a Red Flag
Evidence: 🟢 A · Established
“BMI is all you need to assess obesity.”
Short answer: No — BMI misses fat distribution and confuses muscle with fat.
Evidence: Waist circumference adds independent metabolic-risk information.
Bottom line: Add waist; interpret BMI in context. → BMI & Body Composition
Evidence: 🟢 A · Established
“A normal BMI means I don't need any metabolic testing.”
Short answer: Not necessarily — central fat can carry risk at normal BMI.
Evidence: Waist and metabolic markers can be abnormal despite normal BMI, especially in some ethnic groups.
Bottom line: Risk lives in the waist and labs, not only the BMI box.
Evidence: 🟡 B · Promising
“My thyroid must be why I'm overweight.”
Short answer: Rarely, if TSH is normal.
Evidence: Hypothyroidism causes modest gain; a normal TSH largely excludes it as a major driver.
Bottom line: Worth checking once; seldom the answer. → Hashiexperts
Evidence: 🟢 A · Established
“I need my fasting insulin and HOMA-IR checked to lose weight.”
Short answer: Not a useful routine target for most people.
Evidence: Fasting insulin/HOMA-IR are noisy and rarely change management.
Bottom line: Treat adiposity and metabolic health, not the insulin number. → Weight-Loss Lab Library
Evidence: 🟠 C · Limited
“Normal liver enzymes mean my liver is fine.”
Short answer: No — MASLD, including advanced fibrosis, can occur with normal ALT/AST.
Evidence: Enzymes measure injury, not fat or scar; FIB-4 risk-stratifies better.
Bottom line: Assess fibrosis risk, not just enzymes. → Do I Have Fatty Liver?
Evidence: 🟢 A · Established
“I don't need a sleep study — I'm just tired.”
Short answer: Obstructive sleep apnea is under-diagnosed and worth testing when suspected.
Evidence: OSA worsens metabolic and cardiovascular health and is treatable; symptoms guide testing.
Bottom line: Screen for it — it changes health and, sometimes, treatment.
Evidence: 🟢 A · Established
“My belly fat proves I have a cortisol problem.”
Short answer: Rarely — true cortisol excess (Cushing's) is uncommon and has a specific picture.
Evidence: Central fat alone doesn't diagnose Cushing's; striae, bruising and weakness do.
Bottom line: Test cortisol only when the picture fits.
Evidence: 🟢 A · Established
“I have adrenal fatigue causing my weight.”
Short answer: "Adrenal fatigue" is not a recognized medical diagnosis.
Evidence: No reliable evidence supports it; symptoms have other explanations.
Bottom line: Skip adrenal-fatigue testing.
Evidence: ⚫ E · Unsupported
“A commercial 'metabolism panel' will tell me why I can't lose weight.”
Short answer: Usually not — these panels rarely change management.
Evidence: Marketed "functional-medicine" and "hormone imbalance" panels generate false positives, not answers.
Bottom line: Money spent, little gained. → Weight-Loss Lab Library
Evidence: ⚫ E · Unsupported
“Testosterone testing (and treatment) will fix my weight.”
Short answer: Testosterone is for genuine hypogonadism, not weight loss.
Evidence: Excess fat often lowers testosterone; weight loss frequently raises it.
Bottom line: Check when symptomatic; don't treat weight with testosterone. → TestoExperts (forthcoming)
Evidence: 🟡 B · Promising
“Body composition scans (DXA/BIA) are essential for everyone.”
Short answer: Useful but not required for all.
Evidence: Helpful for tracking fat vs lean mass over time, especially in rapid loss; a single reading can mislead.
Bottom line: Nice for tracking, not mandatory.
Evidence: 🟡 B · Promising
“PCOS should be tested in every woman with weight gain.”
Short answer: No — evaluate when the picture fits.
Evidence: Irregular cycles, androgen excess or fertility concerns warrant it; it isn't a universal reflex.
Bottom line: Targeted, not routine. → PCOS & Weight
Evidence: 🟢 A · Established
“Since diet isn't working, I must have a hidden endocrine disease.”
Short answer: Usually it's set-point biology, not an occult disorder.
Evidence: The body defends weight hormonally after loss, mimicking a "broken metabolism" with normal tests.
Bottom line: Hard-to-lose weight is common and rarely a discrete endocrine disease. → Why Is Weight So Hard to Lose?
Evidence: 🟢 A · Established
“My weight can't be a medication side effect.”
Short answer: It often can be.
Evidence: Steroids, some antipsychotics/antidepressants, insulin, sulfonylureas and others cause real gain.
Bottom line: Always review the medication list. → When Weight Change Is a Red Flag
Evidence: 🟢 A · Established
“Screening for binge eating isn't necessary.”
Short answer: It is — binge-eating disorder is common in people seeking weight care.
Evidence: Recognizing it changes treatment and prevents harm from the wrong approach.
Bottom line: Ask about eating behaviour routinely. → Mental Health & Obesity
Evidence: 🟢 A · Established
“Genetic testing should be done for all obesity.”
Short answer: No — reserve it for suggestive cases.
Evidence: Consider with early-onset severe obesity, extreme hyperphagia, developmental features or family pattern; some rare forms have targeted therapy.
Bottom line: Targeted, not universal. → Genetics of Obesity
Evidence: 🟡 B · Promising
“If all my labs are normal, my weight is my fault.”
Short answer: No — normal labs don't make obesity a moral failing.
Evidence: Genetics, environment, appetite biology and medications drive most obesity with normal standard labs.
Bottom line: Normal results ≠ personal failure. → Obesity as a Chronic Disease
Evidence: 🟢 A · Established
“More tests always mean better care.”
Short answer: No — tests that won't change management add cost and false positives, not value.
Evidence: Over-testing produces incidental findings and anxiety without improving outcomes.
Bottom line: Ask what a result would change; if nothing, reconsider the test.
Evidence: 🟢 A · Established
“A hypothalamic or pituitary cause is too rare to ever consider.”
Short answer: Rare, but not never — specific features should prompt it.
Evidence: Rapid/severe gain with headaches, visual changes, menstrual disturbance or a history of brain injury/surgery/radiation warrants evaluation.
Bottom line: Consider it when the story fits. → When Weight Change Is a Red Flag
Evidence: 🟡 B · Promising
“Waist circumference is too crude to bother measuring.”
Short answer: On the contrary — it's cheap and high-yield.
Evidence: Waist reflects visceral fat and adds metabolic-risk information beyond BMI.
Bottom line: Measure it every time.
Evidence: 🟢 A · Established
Questions patients ask
What tests should I expect when obesity is evaluated?
Adiposity measurement (BMI and waist), a screen for what obesity harms (blood pressure, A1c/glucose, lipids, liver with FIB-4, sleep apnea when suspected), a one-time thyroid check, and a medication and eating-behaviour review. Not a giant hormone panel. Grade A 🟢 → The W8Experts Clinical Approach
Do I need a full hormone panel to find out why I gained weight?
Usually not. Broad reflex hormone testing mostly returns normal and rarely changes management. Deeper endocrine testing is added only when specific signs point to a condition like PCOS, Cushing's or a pituitary problem. Grade A 🟢 → Obesity & Hormones
If all my labs are normal, does that mean it's my fault?
No. Normal labs don't make obesity a willpower problem — genetics, appetite biology, environment and medications drive most obesity with entirely normal standard tests. Normal results should reassure you, not shame you. Grade A 🟢 → Obesity as a Chronic Disease
When does obesity actually need a deeper (secondary) workup?
When the story points there: a weight-driving medication, features of hypothyroidism or Cushing's, PCOS symptoms, rapid or severe gain with neurological or pituitary features, or early-onset severe obesity suggesting a genetic cause. Grade B 🟡 → When Weight Change Is a Red Flag
KEEP READING (Related block)
- When Weight Change Is a Red Flag — the secondary causes worth ruling out, and when to investigate.
- Obesity & Hormones — which hormone tests change management, and which just cost money.
- Do I Have Fatty Liver? — how we screen for liver risk, not just liver fat.
- BMI, Body Fat & Body Composition — why waist and composition beat BMI alone.
- The W8Experts Clinical Approach — how "test what matters" fits our whole method.
Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: 2026-08-10 · References: AACE/ACE and Obesity Medicine Association obesity evaluation guidance; Endocrine Society statements on obesity and secondary causes; AASLD Practice Guidance on MASLD (2023) and FIB-4 risk stratification; PCOS diagnostic guidelines; screening literature for obstructive sleep apnea and binge-eating disorder. Cross-references: Hashiexperts (thyroid), MenoExperts (menopause), TestoExperts (men's hormones — forthcoming). Educational; not individualized medical advice.
